• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
Sinovac Biotech Ltd. is a holding company, which engages in the research, development, and trade of pharmaceutical products. It operates through the Mainland China and Hong Kong geographical segments. It develops and markets human vaccines under the following brands: Inlive, Healive, Bilive, Anflu, PANFLU.1, and Panflu. The company was founded in 1993 and is headquartered in Beijing, China.
Market Cap | 639.904 Million | Shares Outstanding | 98.903 Million | Avg 30-day Volume | 8.297 Thousand |
P/E Ratio | 5.9673 | Dividend Yield | 0.0 | EPS | 1.08 |
Price to Revenue | 0.4313 | Debt to Equity | 0.0009 | EBITDA | -7.719 Million |
Price to Book Value | 0.0722 | Operating Margin | -31.221799999999998 | Enterprise Value | -7.536 Billion |
Current Ratio | 11.109 | EPS Growth | -0.987 | Quick Ratio | 10.855 |
1 Yr BETA | 0.3431 | 52-week High/Low | 0.0 / | Profit Margin | 5.9039 |
Operating Cash Flow Growth | -105.0203 | Free Cash Flow to Firm (FCFF) TTM | -2.68 Billion | Free Cash Flow to Equity (FCFE) TTM | -2.016 Billion |
Altman Z-Score | 1.9978 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
SINOVAC BIOTECH LTD SVA | 2021-10-15 22:15:04 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 21:45:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 21:15:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 20:45:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 20:15:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 19:45:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 19:15:04 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 18:45:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 18:15:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 17:45:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 17:15:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 16:45:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 16:15:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 15:45:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 15:15:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 14:45:02 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 14:15:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 13:45:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 13:15:03 UTC | -2.2271 | 2.2971 | 7000 |
SINOVAC BIOTECH LTD SVA | 2021-10-15 12:45:03 UTC | -2.2271 | 2.2971 | 7000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
SARATOGA ADVANTAGE TRUST- James Alpha Multi Strategy Alternative Income Portfolio | SVA | -1597.0 shares, $-10332.59 | 2021-02-28 | N-PORT |
James Alpha Funds Trust- Easterly Multi Strategy Alternative Income Fund | SVA | -1597.0 shares, $-10332.59 | 2022-05-31 | N-PORT |